Skip to main navigation

>> Site Menu

  • Our Company
  • Our Pipeline
  • Our Science
  • Join Us
  • INVESTORS & MEDIA
    • Overview
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Investor Resources
Kodiak Sciences

>> Site Menu

  • Our Company
  • Our Pipeline
  • Our Science
  • Join Us
  • INVESTORS & MEDIA
    • Overview
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Investor Resources

SEC Filings

> Financial Info - Sub Nav

  • SEC Filings
  • Quarterly Results
  • Annual Reports

SEC Filings

Filing date Form Filing Group View
Oct 05, 2018 4
3,4,5
0000899243-18-026300.pdf
0000899243-18-026300.rtf
View HTML
Oct 05, 2018 4
3,4,5
0000899243-18-026321.pdf
0000899243-18-026321.rtf
View HTML
Oct 05, 2018 4
3,4,5
0000899243-18-026302.pdf
0000899243-18-026302.rtf
View HTML
Oct 05, 2018 424B4
Registration Statements
0001193125-18-293811.pdf
0001193125-18-293811.rtf
0001193125-18-293811.xls
View HTML
Oct 04, 2018 FWP
Other
0001193125-18-292556.pdf
0001193125-18-292556.rtf
0001193125-18-292556.xls
View HTML
Oct 03, 2018 3
3,4,5
0001638599-18-001156.pdf
0001638599-18-001156.rtf
View HTML
Oct 03, 2018 EFFECT
Other
9999999995-18-002534.pdf
9999999995-18-002534.rtf
View HTML
Oct 03, 2018 3
3,4,5
0000899243-18-026107.pdf
0000899243-18-026107.rtf
View HTML
Oct 03, 2018 3
3,4,5
0000899243-18-026160.pdf
0000899243-18-026160.rtf
View HTML
Oct 03, 2018 3
3,4,5
0000899243-18-026158.pdf
0000899243-18-026158.rtf
View HTML

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Next page Next ›
  • Last page Last »
Displaying 51 - 60 of 69 results

Copyright Morningstar

 
 
 
Disclaimer

Some of the statements on this site are forward-looking. Such statements are inherently subject to known as well as unknown risks and uncertainties, including scientific, business, economic and financial factors and other factors that may cause actual results, performance or achievements of Kodiak Sciences to be materially different from those expected or anticipated in the forward-looking statements. Forward-looking statements speak only as of the date they are posted to this website (unless an earlier date is indicated). Kodiak Sciences does not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Kodiak’s drug candidates are investigational compounds in development and have not received regulatory approval in any country.

Kodiak Sciences

2631 Hanover Street
Palo Alto, CA 94304
info@kodiak.com

Copyright © 2019 Kodiak Sciences Inc..